Syndax Pharmaceuticals
SNDX
SNDX
72 hedge funds and large institutions have $244M invested in Syndax Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
-8
Holders Change %
-10%
% of All Funds
1.65%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
7
Increased
28
Reduced
19
Closed
15
Calls
$635K
Puts
$397K
Net Calls
+$238K
Net Calls Change
+$247K
Top Buyers
| 1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$4.27M |
| 2 |
6CM
2
683 Capital Management
New York
|
$4.03M |
| 3 |
OM
3
Opaleye Management
Boston,
Massachusetts
|
$3.17M |
| 4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$5.66M |
| 5 |
5
BlackRock
New York
|
$18.2M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TI
76
Trexquant Investment
Stamford,
Connecticut
| – | -$353K | -40,274 | Closed |
|
77
Two Sigma Investments
New York
| – | -$271K | -30,930 | Closed |
|
|
HCM
78
Highbridge Capital Management
New York
| – | -$248K | -28,328 | Closed |
|
79
AQR Capital Management
Greenwich,
Connecticut
| – | -$228K | -26,068 | Closed |
|
80
D.E. Shaw & Co
New York
| – | -$202K | -23,063 | Closed |
|
|
HAG
81
HighPoint Advisor Group
Downers Grove,
Illinois
| – | -$102K | -11,110 | Closed |
|
82
Squarepoint
New York
| – | -$89K | -10,216 | Closed |
|
83
Group One Trading
Chicago,
Illinois
| – | -$35K | -4,000 | Closed |
|
84
Parallax Volatility Advisers
San Francisco,
California
| – | -$14K | -1,596 | Closed |
|
|
SO
85
STRS Ohio
Columbus,
Ohio
| – | -$13K | -1,500 | Closed |
|
86
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$11K | -1,200 | Closed |
|